Clinical Trial

Get the Benefits From the Start. Improving Breastfeeding

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2023 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Breastfeeding is beneficial for the physical and mental health of mothers and infants alike. Most new mothers in Denmark intend to breastfeed, however, a substantial proportion do not succeed to breastfeed as intended. In Region Zealand, few women breastfeed than in the rest of Denmark in which may be related to a higher proportion of women being overweight, having socio-economic constraints and a low educational level, all associated with breastfeeding difficulties. There is limited knowledge on how to deliver a tailored support aimed at families at high risk of breastfeeding difficulties in a high-income country. We plan to conduct a study aiming to strengthen breastfeeding support to families at risk of breastfeeding difficulties, delivering at Slagelse Hospital, across healthcare sectors, including obstetric and neonatal departments, primary care and civil society. The study aims to develop, implement, and evaluate a supportive breastfeeding intervention with specific focus on families at high risk of complicated breastfeeding and early breastfeeding cessation - a prospective cohort study in Region Zealand, Denmark. Potentially, results can help reducing inequality in health thus more families achieve exclusive breastfeeding and gain health benefits from breastfeeding
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-15.
Status change: Not Yet Recruiting → Recruiting 2023-06-15
Trial Details
NCT Number NCT05871853
Lead Sponsor Slagelse Hospital
Collaborators: Center for Clinical Research and Prevention, Region Zealand, Steno Diabetes Center Sjaelland
Conditions Breastfeeding
Enrollment 1,600 participants
Start Date 2023-05-25
Primary Completion 2025-10-15 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-06-18